Related Experiment Video
Updated: Jun 6, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Frontotemporal dementia: a review for primary care physicians
Roberto Cardarelli1, Andrew Kertesz, Janice A Knebl
1University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
American Family Physician
|December 3, 2010
Summary
Frontotemporal dementia (FTD) is a common dementia in younger adults, characterized by behavioral and language changes rather than memory loss. Early identification and multidisciplinary care are crucial for managing FTD symptoms.
Area of Science:
- Neurology
- Geriatrics
- Neuroscience
Background:
- Frontotemporal dementia (FTD) is a leading cause of dementia in individuals under 65.
- FTD presents with distinct behavioral and language impairments, differentiating it from Alzheimer disease.
- Key FTD variants include behavioral variant FTD, semantic dementia, and progressive nonfluent aphasia.
Purpose of the Study:
- To outline the core features and diagnostic approaches for Frontotemporal dementia.
- To differentiate FTD from other dementia types like Alzheimer disease.
- To emphasize the role of primary care physicians in FTD management.
Main Methods:
- Clinical history and physical examination are primary diagnostic tools.
- Neuroimaging, particularly magnetic resonance imaging (MRI), aids in identifying focal atrophy and excluding other conditions.
- Distinguishing FTD involves comparing its unique behavioral and language profiles with other dementias.
Main Results:
- FTD is characterized by preserved memory but significant changes in behavior (e.g., social inappropriateness, emotional blunting) and language (e.g., comprehension deficits, nonfluent speech).
- MRI typically reveals focal atrophy in FTD patients.
- A combination of clinical assessment and MRI can effectively distinguish FTD from Alzheimer disease, dementia with Lewy bodies, and vascular dementia.
Conclusions:
- While no cure exists, symptomatic management for FTD is available using medications like SSRIs, antipsychotics, and galantamine.
- Primary care physicians play a vital role in the early detection of FTD.
- Establishing an interdisciplinary team is essential for comprehensive care of FTD patients and their caregivers.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...